"Candida glabrata" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of MITOSPORIC FUNGI commonly found on the body surface. It causes opportunistic infections especially in immunocompromised patients.
| Descriptor ID |
D041221
|
| MeSH Number(s) |
B01.300.107.795.095.400 B01.300.381.147.400 B01.300.930.176.400
|
| Concept/Terms |
Candida glabrata- Candida glabrata
- Candida glabratas
- glabratas, Candida
- Torulopsis glabrata
- Torulopsis glabratas
- glabrata, Torulopsis
|
Below are MeSH descriptors whose meaning is more general than "Candida glabrata".
Below are MeSH descriptors whose meaning is more specific than "Candida glabrata".
This graph shows the total number of publications written about "Candida glabrata" by people in this website by year, and whether "Candida glabrata" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Candida glabrata" by people in Profiles.
-
Arastehfar A, Daneshnia F, Hovhannisyan H, Fuentes D, Cabrera N, Quinteros C, Ilkit M, ?nal N, Hilmioglu-Polat S, Jabeen K, Zaka S, Desai JV, Lass-Fl?rl C, Shor E, Gabaldon T, Perlin DS. Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness. mBio. 2023 10 31; 14(5):e0118023.
-
Memon S, Ghanchi NK, Zafar U, Farooqi J, Zaka S, Jabeen K. Analysis of fks1 and fks2 gene mutations in invasive Candida glabrata strains from Pakistan. Mycoses. 2023 Jan; 66(1):52-58.
-
Memon S, Farooqi J, Zafar U, Naqvi SF, Zafar A, Jabeen K. Antifungal susceptibility profile of invasive Candida glabrata isolates (2009-2020) from a tertiary care hospital laboratory in Pakistan. J Med Microbiol. 2021 Dec; 70(12).
-
Katiyar S, Shiffrin E, Shelton C, Healey K, Vermitsky JP, Edlind T. Evaluation of Polymorphic Locus Sequence Typing for Candida glabrata Epidemiology. J Clin Microbiol. 2016 Apr; 54(4):1042-50.
-
Whaley SG, Caudle KE, Vermitsky JP, Chadwick SG, Toner G, Barker KS, Gygax SE, Rogers PD. UPC2A is required for high-level azole antifungal resistance in Candida glabrata. Antimicrob Agents Chemother. 2014 Aug; 58(8):4543-54.
-
Steier Z, Vermitsky JP, Toner G, Gygax SE, Edlind T, Katiyar S. Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1. Antimicrob Agents Chemother. 2013 Nov; 57(11):5543-7.
-
Westbrook SD, Kirkpatrick WR, Wiederhold NP, Freytes CO, Toro JJ, Patterson TF, Redding SW. Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Mar; 115(3):354-8.
-
Asemota OA, Nyirjesy P, Fox R, Sobel JD. Candida glabrata complicating in vitro pregnancy: successful management of subsequent pregnancy. Fertil Steril. 2011 Feb; 95(2):803.e1-2.
-
Gygax SE, Vermitsky JP, Chadwick SG, Self MJ, Zimmerman JA, Mordechai E, Adelson ME, Trama JP. Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay. Antimicrob Agents Chemother. 2008 Sep; 52(9):3424-6.
-
Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol Microbiol. 2006 Aug; 61(3):704-22.